Omni Partners US’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISLE
GCL
BL
PC
MF
PAMP
FTCM
KIM
Omni Partners US's ISLE Position: Q3 2021 in Review
Omni Partners US reduced its Isleworth Healthcare Acquisition Corporation Common stock (ISLE) stake by 4.3% in Q3 2021, selling an estimated $31K and leaving 70,772 shares worth $695K. The position accounts for 0.04% of the portfolio, ranked #210.
Omni Partners US first reported a position in ISLE in Q2 2021 and has held it in 2 quarters since. The position peaked at $725K in Q2 2021. 71 funds tracked by Wall St. Rank hold ISLE as of Q3 2021.
- Omni Partners US held 70,772 shares of Isleworth Healthcare Acquisition Corporation Common stock worth $695K as of Q3 2021.
- Omni Partners US sold 3,180 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2021, an estimated $31K.
- Isleworth Healthcare Acquisition Corporation Common stock made up 0.04% of Omni Partners US's portfolio in Q3 2021, its #210 holding.
- Omni Partners US first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2021 and has held it in 2 quarters since.
- Omni Partners US's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $725K in Q2 2021.
- 71 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2021.
Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.